194 related articles for article (PubMed ID: 36637704)
1. Molecular characteristics of Asian male BRCA-related cancers.
Kwong A; Ho CYS; Shin VY; Ng ATL; Chan TL; Ma ESK
Breast Cancer Res Treat; 2023 Apr; 198(2):391-400. PubMed ID: 36637704
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
[TBL] [Abstract][Full Text] [Related]
3. BRCA and PALB2 mutations in a cohort of male breast cancer with one bilateral case.
Vietri MT; Caliendo G; D'Elia G; Resse M; Casamassimi A; Minucci PB; Cioffi M; Molinari AM
Eur J Med Genet; 2020 Jun; 63(6):103883. PubMed ID: 32058061
[TBL] [Abstract][Full Text] [Related]
4. Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
Ibrahim M; Yadav S; Ogunleye F; Zakalik D
BMC Cancer; 2018 Feb; 18(1):179. PubMed ID: 29433453
[TBL] [Abstract][Full Text] [Related]
5. Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer.
Fostira F; Saloustros E; Apostolou P; Vagena A; Kalfakakou D; Mauri D; Tryfonopoulos D; Georgoulias V; Yannoukakos D; Fountzilas G; Konstantopoulou I
Breast Cancer Res Treat; 2018 May; 169(1):105-113. PubMed ID: 29335925
[TBL] [Abstract][Full Text] [Related]
6. BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing.
Mitri ZI; Jackson M; Garby C; Song J; Giordano SH; Hortobágyi GN; Singletary CN; Hashmi SS; Arun BK; Litton JK
Oncologist; 2015 Jun; 20(6):593-7. PubMed ID: 25948675
[TBL] [Abstract][Full Text] [Related]
7. Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling.
Calip GS; Kidd J; Bernhisel R; Cox HC; Saam J; Rauscher GH; Lancaster JM; Hoskins KF
Breast Cancer Res Treat; 2021 Jan; 185(1):195-204. PubMed ID: 32918117
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
[TBL] [Abstract][Full Text] [Related]
9. Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.
Deb S; Jene N; ; Fox SB
BMC Cancer; 2012 Nov; 12():510. PubMed ID: 23146383
[TBL] [Abstract][Full Text] [Related]
10. BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
Li A; Xie R; Zhi Q; Deng Y; Wu Y; Li W; Yang L; Jiao Z; Luo J; Zi Y; Sun G; Zhang J; Shi Y; Liu J
Gynecol Oncol; 2018 Oct; 151(1):145-152. PubMed ID: 30078507
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.
Lang GT; Shi JX; Hu X; Zhang CH; Shan L; Song CG; Zhuang ZG; Cao AY; Ling H; Yu KD; Li S; Sun MH; Zhou XY; Huang W; Shao ZM
Int J Cancer; 2017 Jul; 141(1):129-142. PubMed ID: 28294317
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian.
Friedenson B
MedGenMed; 2005 Jun; 7(2):60. PubMed ID: 16369438
[TBL] [Abstract][Full Text] [Related]
14. BRCA2 gene mutations in Slovenian male breast cancer patients.
Besic N; Cernivc B; de Grève J; Lokar K; Krajc M; Novakovic S; Zgajnar J; Teugels E
Genet Test; 2008 Jun; 12(2):203-9. PubMed ID: 18439106
[TBL] [Abstract][Full Text] [Related]
15. Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.
Riahi A; Ghourabi ME; Fourati A; Chaabouni-Bouhamed H
Breast Cancer; 2017 Mar; 24(2):238-244. PubMed ID: 27025497
[TBL] [Abstract][Full Text] [Related]
16. Germline variation in BRCA1/2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients.
Bhaskaran SP; Chandratre K; Gupta H; Zhang L; Wang X; Cui J; Kim YC; Sinha S; Jiang L; Lu B; Wu X; Qin Z; Huang T; Wang SM
Int J Cancer; 2019 Aug; 145(4):962-973. PubMed ID: 30702160
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy.
Ottini L; Silvestri V; Rizzolo P; Falchetti M; Zanna I; Saieva C; Masala G; Bianchi S; Manoukian S; Barile M; Peterlongo P; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D
Breast Cancer Res Treat; 2012 Jul; 134(1):411-8. PubMed ID: 22527108
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.
Kim YC; Zhao L; Zhang H; Huang Y; Cui J; Xiao F; Downs B; Wang SM
Oncotarget; 2016 Feb; 7(8):9600-12. PubMed ID: 26848529
[TBL] [Abstract][Full Text] [Related]
19. Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1/2 Mutation Carriers.
Park JS; Lee ST; Han JW; Kim TI; Nam EJ; Park HS
Clin Breast Cancer; 2018 Oct; 18(5):362-373.e1. PubMed ID: 29673794
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study.
Kang E; Seong MW; Park SK; Lee JW; Lee J; Kim LS; Lee JE; Kim SY; Jeong J; Han SA; Kim SW;
Breast Cancer Res Treat; 2015 May; 151(1):157-68. PubMed ID: 25863477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
